Key examples include: Stimulant-containing supplements (caffeine, synephrine, yohimbine) should be avoided by people taking MAOIs or with uncontrolled hypertension Glucomannan may reduce the absorption of oral medicines
Many effects associated with retatrutide are dose-dependent, meaning they may be more or less relevant at different stages of your treatment protocol
Drug Use You must have used at least one of the following semaglutide or GLP-1 receptor agonist drugs: Ozempic (semaglutide, Novo Nordisk) injectable, approved for Type 2 diabetes Wegovy (semaglutide, Novo Nordisk) injectable, approved for chronic weight management Rybelsus (semaglutide, Novo Nordisk) oral tablet form For vision loss (NAION) claims only, eligibility may also extend to: Mounjaro (tirzepatide, Eli Lilly) Zepbound (tirzepatide, Eli Lilly) Note: Trulicity (dulaglutide) and Saxenda/Victoza (liraglutide) are also GLP-1 drugs but involve different manufacturers and different litigation tracks
It definitely controls my hunger
\Visual Improvement: 90% positive response in retinitis pigmentosa (Human Study)